Biohaven BHVN Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$647.68M+27.1% | -$738.82M+12.7% | -$780.11M+3.0% | -$766.97M-2.7% | -$888.6M-71.8% | ||
| $10.04M+16.0% | $9.92M+26.3% | $9.81M+34.6% | $8.68M+27.0% | $8.66M+29.0% | ||
| $87.59M-2.8% | $112.36M+56.1% | $108.1M+43.9% | $98.73M+46.4% | $90.15M+50.5% | ||
| -$7.7M— | -$6.39M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$23.33M-581% | -$3.53M+56.1% | -$3.05M— | -$9.75M— | -$3.43M— | ||
| -$2.18M-116% | -$174K-101% | $10.36M+33.9% | $12.82M+150% | $13.49M+170% | ||
| -$594.23M+7.9% | -$609.44M-4.6% | -$649.52M-23.3% | -$645.08M-34.4% | -$644.94M-80.8% | ||
| $254K-93.8% | $715K-82.3% | $756K-83.1% | $1.35M-73.5% | $4.07M+47.8% | ||
| $242M-67.4% | $266.88M-64.2% | $457.77M-20.7% | $680.56M+77.2% | $743.26M+252% | ||
| -$175M-71.0% | $0+100% | $182.64M+125% | $17.64M-78.3% | -$102.36M-222% | ||
| —— | —— | —— | —— | -$114.13M-168% | ||
| $368.06M-44.6% | $189.18M-71.6% | $271.28M-57.5% | $347.65M-38.1% | $663.96M+171% | ||
| -$194K— | -$194K— | —— | —— | —— | ||
| $617.76M-8.4% | $439.12M-35.2% | $523.17M-19.5% | $603.43M+13.8% | $674.72M+223% | ||
| —— | —— | —— | $71K+120% | $104K+120% | ||
| $174.42M— | $130.24M— | —— | —— | —— | ||
| —— | $216K+72.8% | $193.25K+106% | $170.5K+173% | $147.75K+373% | ||
| —— | —— | —— | —— | $9.75M+119% | ||
| —— | —— | -$12.39M— | -$1.19M— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$23.33M-581% | -$3.53M+56.1% | -$3.05M— | -$9.75M— | -$3.43M— | ||
| —— | $0-100% | $2.14M-66.7% | $4.28M0.0% | $6.42M+200% | ||
| -$2.18M-116% | -$174K-101% | $10.36M+33.9% | $12.82M+150% | $13.49M+170% | ||
| —— | —— | —— | —— | $70.83M— | ||
| $395M-37.6% | $570M+13.0% | $687M+63.5% | $652M+71.8% | $633.2M+68.3% | ||
| —— | —— | —— | —— | $8.99M+40.6% | ||
| -$194K— | -$194K— | —— | —— | —— | ||
| -$594.49M+8.4% | -$610.15M-4.0% | -$650.27M-22.4% | -$646.43M-33.2% | -$649.01M-80.5% | ||
| -$594.49M+8.4% | -$610.15M-4.0% | -$650.27M-22.4% | -$646.43M-33.2% | -$649.01M-80.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Biohaven generate?
- Biohaven (BHVN) generated -$594.2M in operating cash flow over the trailing twelve months.
- What is Biohaven's free cash flow?
- After $254.0K of capital expenditures, Biohaven's free cash flow was -$594.5M over the trailing twelve months, up 8.4% year over year.
- Where does Biohaven's cash flow data come from?
- Every line is extracted from Biohaven's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.